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Abstract
Background: Genetic and environmental factors play a crucial role in the development of type 2 diabetes mellitus
(T2DM) and obesity. This study aimed to investigate the association of the fat-mass and obesity-associated gene
(FTO) rs9939609 variant with T2DM and body mass index (BMI) among Palestinian population.
Methods: A total of 399 subjects were recruited, of whom 281 were type 2 diabetic patients and 118
normoglycemic subjects. All of them were unrelated, aged > 40 years and recruited within the period 2016–2017.
The A allele of FTO rs9939609 was identified by PCR–RFLP.
Results: Significant association of the minor allele A of FTO rs9939609 and T2DM risk was observed with an allelic
odd ratio of 1.92 (95% CI [1.09–3.29], p = 0.02) adjusted for age and gender, this association partly attenuated when
adjusted for BMI with OR of 1.84, (95%CI [1.04–3.05], p = 0.03). Stratified data by glycemic status across FTO
genotypes showed that A allele was marginally associated with increased BMI among diabetic group (p = 0.057) but
not in control group (p = 0.7). Moreover, no significant association was observed between FTO genotypes and
covariates of age, gender, T2DM complications or any tested metabolic trait in both diabetic and nondiabetic
individuals (p > 0.05).
Conclusions: The variant rs9939609 of the FTO gene was associated with T2DM in Palestine. This is the first study
conducted on this gene in the Palestinian population and provides valuable information for comparison with other
ethnic groups. Further analysis with larger sample size is required to elucidate the role of this variant on the
predisposition to increased BMI in Palestinians.
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Background
Type 2 diabetes mellitus (T2DM) is the most common type
of diabetes as it accounts for more than 90% of all diabetes
cases worldwide (World Health Organization) [1]. Polymor-
phisms within the fat-mass and obesity-associated gene
(FTO) are of particular interest as they have known effect
on obesity which is a major risk factor for T2DM. A
genome-wide association study (GWAS) conducted in
2007, confirmed that rs9939609 variant located within the
first intron of the FTO gene predisposes European
populations to diabetes through an effect on body mass
index (BMI) [2, 3], while other reports from South Asian
population showed that FTO gene variants increase the risk
of type 2 diabetes independent of BMI [4]. Since then,
several studies represent various ethnic populations, con-
firmed strong associations of the FTO rs9939609 with obes-
ity [5, 6]. This association was not replicated in the Chinese
Han population and African Americans [7, 8]. It is
well-established that dyslipidemia is a risk factor for cardio-
vascular diseases (CVD) in diabetic patients. However, a
study conducted by Doney et al. [9] demonstrated that A al-
lele rs9939609 in the FTO gene increases the risk of myo-
cardial infarction in patients with T2DM independent of
BMI, glycated hemoglobin, mean arterial pressure and dys-
lipidemia. Moreover, a significant association of FTO variant
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was found in Indian patients with T2DM without dyslipid-
emia [10].
A sex-specific effect of FTO variants on susceptibility
to obesity have been shown, a study -in 2016- indicated
that the effect of FTO variants on T2DM susceptibility
in Japanese men but not women is mediated through
FTO effect on BMI [11]. In 2018, a case control study
conducted on obese Iranian women showed that several
FTO variants including rs9939609 were associated with
T2DM and obesity as well [12]. A recent spatial and
meta-analysis suggested a region-related associations be-
tween FTO rs9939609 and T2DM [13]. Thus, the re-
ported results were not consistent in different ethnic
population.
In Palestine, the prevalence of DM (for adults aged >
25 years) was 15.3% in 2010, but estimates have placed to
be as high as 20.8% by 2020 [14, 15]. Diabetes and its com-
plications are estimated to account for approximately 5.7%
of all deaths in Palestine [16]. The prevalence of overweight
and obesity is rapidly escalating in the youth and adults,
probably due changes in lifestyle, further enhancing the risk
of diabetes. In 2016, a cross sectional study among the stu-
dents at An-Najah National University in Nablus district
(North Palestine) showed that the prevalence of overweight
and obesity was 26.2%, with significant increase in males
(36.4%) compared to females (19.1%) [17]. Genetic associ-
ation studies of T2DM among Palestinians are scarce. Two
studies conducted by Ereqat and colleagues in 2009 [18, 19]
investigated the genetic association of Pro12Ala Polymorph-
ism of the PPAR-Gamma 2 gene and rs7903146 variant in
the transcription factor 7 like 2 gene (TCF7L2) with T2DM.
However, no studies have been conducted to determine the
genetic association of FTO variants with T2DM and/ or
obesity. Therefore, our study aimed to examine the associ-
ation between the FTO rs9939609 SNP with the risk of
T2DM and its-related phenotypes in Palestinian population.
Methods
Study population
A total of 399 unrelated individuals were recruited from
different cities in Palestine. Two-hundred eighty one
cases, aged > 40 years, were diagnosed by T2DM accord-
ing to WHO criteria based on fasting plasma glucose
126 mg/dl and/or currently being treated with medica-
tion for diabetes. All participants were recruited within
the period of 2016–2017 in collaboration with UNRWA
clinics (Hebron and Ramallah, Palestine). The anthropo-
metric measurements were collected from their medical
records that included age, sex, family history, drug his-
tory, medical history and other related information.
Fasting blood was collected for biochemical tests and
DNA studies. All the cases with probable diagnosis of
type 1 diabetes were excluded. The control group (n =
118), was selected from individuals who came to the
same clinic for health check-up with no past medical
history for T2DM and no family history of diabetes in
first-degree relations. Age at examination was > 40 years.
Biochemical testing, DNA extraction and genotyping
Five milliliters of blood were obtained after overnight
fast, collected in EDTA tubes, centrifuged at room
temperature. Plasma glucose, cholesterol, HDL choles-
terol, and triglyceride were determined by enzymatic
methods as described by manufacturer’s instructions
(Human, Wiesbaden, Germany). Genomic DNA was ex-
tracted from whole blood (300 μl) using genomic DNA
purification kit QIAamp according to the manufacturer
instructions (Qiagen, Hilden, Germany). DNA samples
were stored at 4 °C for further analyses. Genotyping of
the FTO rs9939609 SNP was done by PCR-based restric-
tion fragment length polymorphism (RFLP) analysis as
previously described [20] with the following modifica-
tions. The PCR reactions were carried out using 20 ng
of purified genomic DNA samples, with 0.4 μM of the
forward and reverse primers using PCR-Ready Supreme
mix (Syntezza Bioscience, Jerusalem) in a final volume
of 25 μl. The genotypes patterns were determined by 2%
agarose gel electrophoresis (Agarose; Sigma-Aldrich,
Munich, Germany) stained with Ethiduim bromide. A
5% masked, random sample of cases and controls were
re-amplified and sent for sequencing to confirm the
genotyping method.
Statistical analysis
The genotype frequencies were tested for Hardy–Wein-
berg equilibrium using a chi-square test through the web-
site http://www.oege.org/software/hwe-mr-calc.html. All
statistical analysis was performed using SPSS v23.0 (SPSS,
Chicago, IL). Pearson’s Chi-square test was used to com-
pare allelic and genotypic frequencies between the diabetic
Table 1 Clinical and biochemical characteristics of case and
control groups
cases (n=281) controls (n=118)
Parameters P-value
M:F ratio 94:187 48:70
Age at diagnosis (years) 50.39+11.04 NA
Age at sampling (years) 58.15±12.09 49.62±8.71 0.0001*
BMI 32.9±6.6 29.2±6.2 <0.0001*
SBP (mmHg) 136.21±17.42 122.33±11.44 0.0001*
DBP (mmHg) 80.21±10.83 76.72±9.37 0.0024*
FBS (mg/dl) 163.31±58.72 87.14±7.82 0.0001*
TC (mg/dl) 187.91±47.53 182.15±40.95 0.251
Treatment (OHA,C,I)(n) 204,71,6 NA
Values are expressed as means ±SD, *P<0.05 is considered to be significant
NA Not applicable. Treatment at time of recruitment OHA oral hypoglycemic
agent, C combination of insulin and hypoglycemic agent, I insulin
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and nondiabetic groups. ANOVA was used to assess the
association between FTO genotypes and continuous vari-
ables. Logistic regression by R statistics (V 3.4.4) software
was used to measure odd ratio (OR) for T2DM adjusted
for age, gender and BMI.
Results
Biochemical characteristics of the study participants
The biochemical and anthropometric results of the 281
T2DM patients and 118 nondiabetic subjects are shown
in Table 1. As expected, significant differences in bio-
chemical parameters was observed between the two
groups (p < 0.05). However, the mean total cholesterol
was not significant between diabetic and non diabetic
groups (p = 0.25). Among T2DM group, 64.4% (n = 181)
were obese (BMI > 30 kg/m2), 30.2% (n = 85) were over-
weight (25–29.9 kg/m2) and 5.3% (n = 15) were nonob-
ese (BMI < 30 kg/m2). Of them, 76.6% were treated with
oral hypoglycemic agent, 25.3% received a combination
of insulin and oral hypoglycemic agents and 2.1% were
treated with insulin. Of these patients, 14.6, 12.1, 7.8 and
6% had cardio vascular disease (CVD), nephropathy, dia-
betic foot and retinopathy, respectively. Noteworthy, 75%
of the cases had T2DM first-degree relatives. Among the
control group, 44.1% (n = 52) were obese, 22.9% (n = 27)
were overweight and 33.1% (n = 39) were not obese.
Analysis of FTO variant
FTO genotyping (rs9939609) was performed by PCR
followed by RFLP. The presence of product was verified
on a 2% agarose gel stained with ethidium bromide, a
band of 187 bp was observed as shown in Fig. 1a. The
PCR product was digested by ScaI restriction enzyme and
visualized by 2% agarose gel. A band of 187 bp was ob-
served for the TT genotype, two bands of 154, 33 bp was
observed for the AA genotype while three bands of 187,
154, 33 bp were observed for the heterozygous genotype
AT as shown in Fig. 1b.
Association of FTO variant and T2DM
The genotype and allele frequency of FTO gene poly-
morphism (rs9939609) a;mong the two groups were ana-
lyzed and compared as shown in Table 2. Our results
revealed that carriers of AA genotype was significantly
higher in T2DM subjects compared to non diabetic indi-
viduals (36%) vs (16%))(p = 0.003). The genotyping distri-
bution was in line of Hardy Weinberg equilibrium in all
cases and controls (p= > 0.05). Logistic regression ana-
lysis was performed for AT and AA genotypes with TT
as a reference genotype. We found that the AT genotype
conferred 2.1 times higher risk for T2DM compared to
TT genotypes unadjusted p < 0.0001 (Table 3). As our
controls were younger than diabetic cases, logistic re-
gression model adjusted for age and gender was used,
and showed that allelic odd ratio was 1.92 (95% CI
[1.09–3.29], p = 0.02). This association remained signifi-
cant even after adjusting for age, gender and BMI (OR
1.84, 95%CI (1.04–3.05)). The highest risk was observed
among AA carriers compared to those with TT geno-
types (OR 4.03, 95% CI (2.01–8.06) p < 0.0001) as shown
in Table 3.
Fig. 1 Agarose gel electrophoresis (2%) of FTO gene variant (a) PCR products showing 187 bp amplicon (Lanes 1–5), lane 6: Negative control,
lane 7: 50 bp ladder. (b) Digested PCR product representing different genotypes: Lanes 1, 3: AT genotype; Lanes 2, 5: AA genotype; Lane 4: TT
genotype; Lane 7: 50 bp ladder
Table 2 Allelic and genotypic frequency of FTO variant
(rs9939609) among T2DM cases and controls
Genotype cases(n) Controls (n) All Subjects (n)
TT 51 45 96
AT 129 54 183
AA 101 19 120
A allele (%) 58.8 38.9 53
Sabarneh et al. BMC Medical Genetics  (2018) 19:156 Page 3 of 6
Association of FTO variant with BMI
The entire data including all the study subjects (n = 399)
was stratified based on FTO genotypes, a significant as-
sociation was found between FTO genotypes and mean
BMI, the AA genotypes had the highest BMI (33.29 ±
7.2), unadjusted p = 0.03. Because of potential confound-
ing between T2DM and increased BMI as proxy meas-
ure of obesity, the data was stratified by glycemic status
across FTO genotypes. Among diabetic group, a trend of
increasing mean BMI was observed among the three ge-
notypes: AA carriers had the highest BMI (34.11 ± 7.1)
compared to AT (32.32 ± 6.1) and TT carriers (31.86 ±
6.5) but it was not significant (p = 0.057). However, this
increasing trend was not found among the control group
(p = 0.7) as shown in Table 4. Furthermore, no associ-
ation was found between the FTO genotype and gender,
age, plasma total cholesterol, as well as systolic and dia-
stolic blood pressure among the two groups. Among dia-
betic group, no association was found between the FTO
genotype and cardio vascular disease or diabetes compli-
cations (p > 0.05).
Discussion
To our knowledge, this study is the first to investigate
the association of the FTO variant rs9939609 with type 2
diabetes and BMI in Palestine. The significance of com-
mon variants in the FTO gene for susceptibility to adi-
posity have been highlighted by large-scale studies
among Europeans while conflicting results were reported
in Asian populations [21, 22]. Our study showed a sig-
nificant association of FTO variant rs9939609 with
T2DM after adjustment by age and gender with an al-
lelic odds ratio of 1.92 (95% CI [1.09–3.29], p = 0.02).
Moreover, we noted that the association of FTO variant
rs9939609 with T2DM was partially attenuated by
adjusting for BMI with odd ratio of 1.84, 95%CI (1.04–
3.05) p = 0.03, suggesting that the FTO -T2DM associ-
ation was not completely mediated through FTO variant
effect on BMI. Similar results were found in Indian,
American and Chinese populations [4, 10, 23]. Vasan
and colleagues [24] provided evidence that FTO-T2DM
risk -among Asian Indians- was attenuated but not fully
abolished when adjusting to BMI. In contrast, a recent
study conducted in Kuwaiti population did not observe an
association between the FTO rs9939609 with T2DM risk
[25]. Two studies in North Indians and Asian Indians
demonstrated a strong association of FTO rs9939609 with
T2DM independent of BMI [4, 26]. However, contradict-
ory results for association of FTO variants with T2DM
have been reported in different ethnic groups of India
[27]. Furthermore, a meta-analysis study conducted in
South Asia showed that BMI and central obesity can
partly account for the association of A allele of the FTO
gene and diabetes, whereas this association was much re-
duced when adjusted for BMI in Europeans indicating
ethnic-specific associations [28]. On the other hand, sev-
eral studies revealed a strong association between different
variants within the FTO gene and BMI or diabetes sup-
porting that the impact of FTO on obesity or diabetes is
population-dependent [29–32]. A recent study conducted
by Wang and colleagues [33] showed that FTO protein ex-
pression in T2DM patients was higher than in healthy
controls which was positively correlated with T2DM se-
verity, BMI and waist circumference.
Our study revealed that, among all study subjects, the TT
carriers had lower BMI compared to AT and AA carriers
(unadjusted p = 0.03) but when the mean BMI was stratified
by glycemic status across FTO genotypes, the association
with BMI was lost in the control group (p= 0.7). In diabetic
group, an additive trend of the allele A with increased BMI
was observed but was not significant (p = 0.057). However,
further studies with larger sample size and greater statistical
Table 4 Mean trait values stratified by glycemic status across FTO genotypes
T2DM (n=281) Control (n=118)
AA AT TT *P-value AA AT TT *P-value
Number 101 129 51 19 54 45
BMI (kg/m2) 34.11±7.1 32.32±6.1 31.86±6.5 0.057 28.89±6.96 29.77±6.1 28.75±5.8 0.688
SBP (mmHg) 133.94±16.9 138.26±16.4 135.47±20.4 0.166 119.3±16.3 124.2±10.7 121.4±9.5 0.222
DBP (mmHg) 78.68±11.9 80.94±10.1 81.35±10.5 0.206 72.8±9.2 76.7±10.2 78.5±8.1 0.087
FBS (mg/dl) 159.11±54.3 163.97±58.9 169.94±65.6 0.553 85.9±6.9 87.7±7.4 86.9±8.8 0.693
TC (mg/dl) 189.16±49.3 188.57±49.2 183.71±39.8 0.783 168.1±40.1 188.5±48.8 180.4±28.2 0.165
*P<0.05 was considered significant, obtained by ANOVA. Values are expressed as means ±SD. Bold number showed marginally significant association between A
allele and increased BMI among diabetic group
Table 3 Association of FTO variant (rs9939609) with T2DM
Genotype OR( 95% CI ) P-value OR(95% CI) *P-value
AA vs TT 4.69 (2.49–8.83) <0.0001 4.03 (2.01–8.06) <0.0001*
AT vs TT 2.11 (1.26-3.52) <0.0001 1.84 (1.04-3.05) 0.034*
AA vs
(AT+TT) 2.78 (1.72-4.49) <0.0001 2.71 (1.5-4.9) 0.001*
*P values were from logistic regression models adjusted for age, gender and
BMI, P<0.05 was considered significant
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power are needed to replicate these findings. In 2016, a
study conducted on Egyptian children and adolescents
didn’t show an association between the polymorphism
rs9939609 and BMI. However, that study revealed a signifi-
cant correlation between LDL and FTO rs9939609 support-
ing the idea that this variant can be a determinant of
obesity due to its effect on the lipid profile [34].
The high prevalence of obesity among our diabetic and
control group (64 and 44%, respectively) could be attributed
to other variants within FTO and or other genes which can
be modulated by environmental factors and lifestyle. Any-
how, as our diabetic cases were older and had higher BMI
than controls, we adjusted for the possible confounding
effect of age, sex, and BMI in all the logistic regression
analyses while investigating T2DM risk across FTO geno-
types. Recently, a study conducted by Celis-Morales et al.
[35] reported that physical activity attenuates the effect of
FTO on BMI. Another study conducted on Emirati people
showed that the AA carriers who were physically active
had a lower mean BMI than those who were physically in-
active, while other studies conducted on African Ameri-
cans and Europeans showed no such interaction [36, 37].
Furthermore, a recent cross sectional study in a multieth-
nic population suggested that high dietary protein intake
may protect against the effects of risk variants in the FTO
gene on BMI and waist circumference [28]. In this study
and due to the lack of data regarding physical activity or
diet intake, we were unable to examine the influence of
physical activity /diet on the impact of FTO variant on
BMI. Although FTO -T2DM association was found, the
lack of association between FTO rs9939609 and obesity is
most probably due to the small sample size -and thereby
decreased statistical power- which was the most important
limitation in this study and thus larger sample size is re-
quired to verify these results. However, weight, skinfold
thicknesses, body fat percentage and waist circumference
are reported to be more reliable markers of obesity than
BMI [38]. We believe that obesity-related genetic variants
also modulate glucose–insulin secretion. Therefore, leaner
cases should be recruited while investigating gene–T2DM
association among Palestinians.
On the other hand, we did not find any association of
FTO rs9939609 with the T2DM complications and the
prevalence of CVD among the studied population. This
is consistent with recent findings showing no association
of FTO rs9939609 variant with diabetic retinopathy and
nephropathy [39]. However, a meta-analysis study re-
ported significant association of the FTO rs9939609 vari-
ant with CVD risk, which was independent of BMI and
other conventional CVD risk factors [40].
Conclusion
The FTO rs9939609 variant was significantly associated
with T2DM in Palestine. However, further analysis with
larger sample size and data on physical activity and diet
intake is required to elucidate the role of this variant
and other variants of FTO gene on the predisposition to
increased BMI in Palestinians.
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